Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: September 03, 2022
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia.
Journal: Clinical pharmacology and therapeutics
Published: May 21, 2021
Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method.
Journal: Research and practice in thrombosis and haemostasis
Published: August 18, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2019
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States.
Journal: Clinical epidemiology
Published: August 30, 2019
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 29, 2018
Systematic literature review of treatments used for adult immune thrombocytopenia in the second-line setting.
Journal: American journal of hematology
Published: June 08, 2018
A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice.
Journal: Cancer immunology, immunotherapy : CII
Published: September 06, 2017
Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.
Journal: Current medical research and opinion
Published: July 28, 2017
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.
Journal: Immunotherapy
Published: December 22, 2016
Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States.
Journal: Clinical therapeutics
Published: September 15, 2016
Last Updated: 09/26/2026